| Literature DB >> 30044228 |
Yi Hu1, Lin Ji1, Yan Zhang1, Rong Shi1, Wenchao Han2, Lap Ah Tse3, Rui Pan1, Yiwen Wang2, Guodong Ding4, Jian Xu2, Qingying Zhang5, Yu Gao1, Ying Tian1,2.
Abstract
BACKGROUND: Pesticides have been associated with reproductive disorders, but there is limited research on pesticide exposures and human fertility.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30044228 PMCID: PMC6108871 DOI: 10.1289/EHP2987
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1.Flowchart for participant selection.
Characteristics of the study population at enrollment and their associations with time to pregnancy, pregnancy, and infertility.
| Characteristic | Study population ( | TTP (months) ( | Pregnancy ( | Infertility ( | ||
|---|---|---|---|---|---|---|
| Maternal age (years) | — | 0.023 | 0.271 | |||
| Prepregnancy BMI ( | — | 0.094 | 0.017 | |||
| Age at menarche (years) | — | 0.323 | 0.660 | |||
| Current smoking | ||||||
| No | 453 (73.5) | 4.5 (2.0–10.0) | 0.035 | 293 (80.3) | 96 (73.3) | 0.204 |
| Live with smoker | 153 (24.9) | 5.5 (2.0–12.0) | 68 (18.6) | 32 (24.4) | ||
| Yes | 9 (1.5) | 10.0 (6.5–12.0) | 4 (1.1) | 3 (2.3) | ||
| Education | ||||||
| | 117 (19.0) | 5 (2.0–9.5) | 0.988 | 62 (17.0) | 20 (15.3) | 0.650 |
| | 498 (81.0) | 5 (2.0–10.0) | 303 (83.0) | 111 (84.7) | ||
| Annual household income (CNY) | ||||||
| | 140 (22.8) | 4.0 (2.0–10.0) | 0.363 | 84 (23.0) | 29 (22.1) | 0.496 |
| 150,000–300,000 | 329 (53.5) | 4.5 (1.5–10.0) | 201 (55.1) | 65 (49.6) | ||
| | 106 (17.2) | 6.0 (2.0–12.0) | 59 (16.1) | 27 (20.6) | ||
| Refused to answer | 40 (6.5) | 6.0 (2.0–12.0) | 21 (5.8) | 10 (7.6) | ||
| Parity | ||||||
| 0 | 569 (92.5) | 5.0 (2.0–10.0) | 0.062 | 334 (91.5) | 121 (92.4) | 0.759 |
| | 46 (7.5) | 4.0 (2.0–7.0) | 31 (8.5) | 10 (7.6) | ||
| Have you found that you could not cope with all the things that you had to do? | ||||||
| Never or almost never | 267 (43.4) | 5.0 (2.0–9.0) | 0.239 | 175 (48.0) | 43 (32.8) | 0.013 |
| Sometimes | 333 (54.2) | 5.5 (2.0–12.0) | 183 (50.1) | 84 (64.1) | ||
| Fairly often or very often | 15 (2.4) | 3.0 (1.0–12.0) | 7 (1.9) | 4 (3.1) | ||
| How often have you been able to control irritations in your life? | ||||||
| Never or almost never | 27 (4.4) | 4.0 (2.0–8.0) | 0.078 | 17 (4.7) | 5 (3.8) | 0.023 |
| Sometimes | 168 (27.3) | 4.0 (1.5–8.0) | 104 (28.5) | 22 (16.8) | ||
| Fairly often or very often | 420 (68.3) | 5.5 (2.0–12.0) | 244 (66.8) | 104 (79.4) | ||
Note: —, data not available; BMI, body mass index; IQR, interquartile range; SD, standard deviation; TTP, time to pregnancy.
p-Values for difference in time to pregnancy according to characteristics at enrollment; Spearman correlation for continuous variables, rank sum test for categorical variables.
p-Values for differences in characteristics at enrollment according to pregnancy or infertile status at the end of follow-up; t test for continuous variables, chi-square test for categorical variables.
Questions from the PSS-10 questionnaire.
Urinary concentrations of organophosphate (OP) and pyrethroid (PYR) metabolites ().
| Pesticides | Metabolites | Detection rate | Adjustment | Percentile | |||
|---|---|---|---|---|---|---|---|
| 25th | 50th | 75th | 95th | ||||
| OPs | DMP | 579 (94.1) | Unadjusted | 2.03 | 4.83 | 11.31 | 45.43 |
| Adjusted | 2.99 | 6.99 | 16.14 | 53.83 | |||
| DMTP | 572 (93.0) | Unadjusted | 0.75 | 1.77 | 4.67 | 21.47 | |
| Adjusted | 1.25 | 2.79 | 5.97 | 22.14 | |||
| DEP | 614 (99.8) | Unadjusted | 3.99 | 7.22 | 13.60 | 31.54 | |
| Adjusted | 5.86 | 10.25 | 16.63 | 35.59 | |||
| DETP | 615 (100) | Unadjusted | 1.25 | 2.54 | 5.13 | 16.34 | |
| Adjusted | 2.16 | 3.47 | 6.43 | 15.48 | |||
| DMDTP | 87 (14.1) | Unadjusted | 0.60 | ||||
| Adjusted | 1.18 | ||||||
| DEDTP | 172 (28.0) | Unadjusted | 0.28 | 0.65 | |||
| Adjusted | 0.31 | 1.40 | |||||
| Total DAP | 108.50 | 198.43 | 335.51 | 766.22 | |||
| PYRs | 3PBA | 609 (99.0) | Unadjusted | 0.29 | 0.51 | 1.04 | 3.14 |
| Adjusted | 0.44 | 0.73 | 1.31 | 3.99 | |||
| TDCCA | 368 (59.8) | Unadjusted | 0.29 | 0.59 | 2.22 | ||
| Adjusted | 0.44 | 0.82 | 3.35 | ||||
| CDCCA | 85 (13.8) | Unadjusted | 0.94 | ||||
| Adjusted | 1.82 | ||||||
Note: 3PBA, 3-phenoxybenzoic acid; CDCCA, cis-3-(2,2-dichlorovinyl)-1-methylcyclopropane-1,2-dicarboxylic acid; DEDTP, diethyldithiophosphate; DEP, diethylphosphate; DETP, diethylthiophosphate; DMDTP, dimethyldithiophosphate; DMP, dimethylphosphate; DMTP, dimethylthiophosphate; LOD, limit of detection; OP, organophosphate; PYR, pyrethroid; TDCCA, trans-3-(2,2-dichlorovinyl)-1-methylcyclopropane-1,2-dicarboxylic acid.
Not adjusted for creatinine ().
Adjusted for creatinine ( creatinine).
Total DAP was the summary of molar concentrations of DMP, DMTP, DEP, and DETP ( creatinine).
Fecundability odds ratios and 95% confidence intervals for preconception organophosphate and pyrethroid exposure ().
| Exposure ( | FOR (95% CI) | |||
|---|---|---|---|---|
| All women ( | Nulliparous women ( | |||
| Unadjusted | Adjusted | Unadjusted | Adjusted | |
| OPs | ||||
| DMP | ||||
| Continuous | 0.97 (0.82, 1.15) | 0.97 (0.82, 1.15) | 0.97 (0.82, 1.15) | 0.99 (0.83, 1.17) |
| Q1 ( | Reference | Reference | Reference | Reference |
| Q2 (2.99–6.99) | 1.04 (0.78, 1.38) | 1.03 (0.77, 1.37) | 1.04 (0.78, 1.40) | 1.02 (0.76, 1.38) |
| Q3 (6.99–16.14) | 0.98 (0.73, 1.30) | 0.93 (0.69, 1.24) | 0.97 (0.72, 1.30) | 0.91 (0.68, 1.24) |
| Q4 ( | 0.88 (0.66, 1.18) | 0.85 (0.63, 1.15) | 0.90 (0.66, 1.29) | 0.86 (0.64, 1.17) |
| | 0.955 | 0.883 | 0.958 | 0.836 |
| DMTP | ||||
| Continuous | 1.09 (0.89, 1.33) | 1.06 (0.86, 1.29) | 1.08 (0.88, 1.33) | 1.07 (0.97, 1.32) |
| Q1 ( | Reference | Reference | Reference | Reference |
| Q2 (1.25–2.79) | 0.87 (0.65, 1.17) | 0.91 (0.67, 1.23) | 0.88 (0.65, 1.20) | 0.90 (0.66, 1.23) |
| Q3 (2.79–5.97) | 0.97 (0.73, 1.30) | 0.97 (0.73, 1.30) | 0.98 (0.72, 1.32) | 0.97 (0.71, 1.31) |
| Q4 ( | 1.12 (0.85, 1.49) | 1.15 (0.86, 1.53) | 1.17 (0.87, 1.32) | 1.19 (0.89, 1.60) |
| | 0.589 | 0.734 | 0.670 | 0.717 |
| DEP | ||||
| Continuous | 0.90 (0.68, 1.19) | 0.90 (0.67, 1.20) | 0.89 (0.67, 1.20) | 0.91 (0.67, 1.23) |
| Q1 ( | Reference | Reference | Reference | Reference |
| Q2 (5.86–10.25) | 1.04 (0.78, 1.40) | 1.05 (0.78, 1.41) | 1.06 (0.78, 1.43) | 1.02 (0.75, 1.38) |
| Q3 (10.25–16.63) | 1.11 (0.83, 1.47) | 1.12 (0.84, 1.50) | 1.08 (0.80, 1.46) | 1.08 (0.80, 1.47) |
| Q4 ( | 1.05 (0.78, 1.40) | 1.08 (0.81, 1.45) | 1.03 (0.76, 1.39) | 1.04 (0.77, 1.41) |
| | 0.635 | 0.601 | 0.997 | 0.778 |
| DETP | ||||
| Continuous | 1.07 (0.81, 1.41) | 1.09 (0.82, 1.45) | 1.07 (0.80, 1.43) | 1.10 (0.82, 1.48) |
| Q1 ( | Reference | Reference | Reference | Reference |
| Q2 (2.16–3.47) | 0.88 (0.66, 1.16) | 0.85 (0.64, 1.13) | 0.88 (0.66, 1.17) | 0.83 (0.61, 1.11) |
| Q3 (3.47–6.43) | 0.82 (0.62, 1.10) | 0.84 (0.63, 1.12) | 0.77 (0.57, 1.04) | 0.78 (0.58, 1.06) |
| Q4 ( | 0.71 (0.53, 0.95) | 0.68 (0.51, 0.92) | 0.71 (0.52, 0.96) | 0.67 (0.50, 0.91) |
| | 0.235 | 0.153 | 0.231 | 0.143 |
| Total DAP | ||||
| Continuous | 0.93 (0.69, 1.27) | 0.94 (0.70, 1.26) | 0.92 (0.68, 1.25) | 0.95 (0.70, 1.28) |
| Q1 ( | Reference | Reference | Reference | Reference |
| Q2 (108.5–198.43) | 1.06 (0.79, 1.42) | 1.07 (0.80, 1.43) | 1.06 (0.78, 1.43) | 1.04 (0.77, 1.41) |
| Q3 (198.43–335.51) | 0.96 (0.72, 1.29) | 0.79 (0.58, 1.08) | 0.94 (0.70, 1.28) | 0.87 (0.64, 1.19) |
| Q4 ( | 1.08 (0.81, 1.44) | 0.90 (0.67, 1.21) | 1.07 (0.79, 1.44) | 1.03 (0.76, 1.39) |
| | 0.874 | 0.988 | 0.914 | 0.873 |
| PYR | ||||
| 3PBA | ||||
| Continuous | 1.14 (0.88, 1.48) | 1.19 (0.91, 1.54) | 1.19 (0.91, 1.56) | 1.23 (0.93, 1.61) |
| Q1 ( | Reference | Reference | Reference | Reference |
| Q2 (0.44–0.73) | 0.86 (0.65, 1.14) | 0.83 (0.62, 1.11) | 0.82 (0.61, 1.11) | 0.80 (0.60, 1.08) |
| Q3 (0.73–1.31) | 0.88 (0.66, 1.17) | 0.85 (0.63, 1.13) | 0.84 (0.63, 1.12) | 0.83 (0.62, 1.11) |
| Q4 ( | 0.75 (0.56, 1.00) | 0.77 (0.57, 1.03) | 0.74 (0.54, 0.99) | 0.72 (0.53, 0.98) |
| | 0.216 | 0.160 | 0.121 | 0.089 |
Note: 3PBA, 3-phenoxybenzoic acid; CI, confidence interval; DAP, dialkyl phosphate; DEP, diethylphosphate; DETP, diethylthiophosphate; DMP, dimethylphosphate; DMTP, dimethylthiophosphate; FOR, fecundability odds ratio; OP, organophosphate; PYR, pyrethroid; Q1–4, quartiles 1–4.
.
Urine concentrations of pesticide metabolites were adjusted for creatinine then .
Adjusted for age, prepregnancy body mass index (BMI), age at menarche, current smoking, education, annual household income, “Have you found that you could not cope with all the things that you had to do?”, and “How often have you been able to control irritations in your life?” in Cox models.
Odds ratios and 95% confidence intervals for preconception organophosphate and pyrethroid exposure ().
| Exposure ( | OR (95% CI) | |||||||
|---|---|---|---|---|---|---|---|---|
| All women ( | Nulliparous women ( | |||||||
| Pregnancy | Infertility | Unadjusted | Adjusted | Pregnancy | Infertility | Unadjusted | Adjusted | |
| OPs | ||||||||
| DMP | ||||||||
| Continuous | 1.04 (0.75, 1.44) | 1.03 (0.74, 1.44) | 1.02 (0.72, 1.43) | 0.98 (0.69, 1.38) | ||||
| Q1 ( | 96 | 29 | Reference | Reference | 89 | 27 | Reference | Reference |
| Q2 (2.99–6.74) | 84 | 39 | 0.92 (0.51, 1.64) | 0.94 (0.51, 1.72) | 72 | 36 | 0.90 (0.50, 1.64) | 0.97 (0.52, 1.81) |
| Q3 (6.74–16.17) | 91 | 32 | 1.41 (0.81, 2.46) | 1.60 (0.90, 2.84) | 84 | 28 | 1.48 (0.83, 2.64) | 1.74 (0.96, 3.17) |
| Q4 ( | 94 | 31 | 1.07 (0.60, 1.89) | 1.13 (0.63, 2.05) | 89 | 30 | 0.99 (0.55, 1.79) | 1.07 (0.58, 1.98) |
| | 0.710 | 0.483 | 0.706 | 0.415 | ||||
| DMTP | ||||||||
| Continuous | 0.81 (0.54, 1.23) | 0.83 (0.54, 1.26) | 0.77 (0.50, 1.19) | 0.79 (0.51, 1.24) | ||||
| Q1 ( | 89 | 34 | Reference | Reference | 77 | 32 | Reference | Reference |
| Q2 (1.31–2.85) | 86 | 38 | 1.28 (0.73, 2.28) | 1.30 (0.72, 2.35) | 82 | 35 | 1.40 (0.76, 2.56) | 1.42 (0.76, 2.66) |
| Q3 (2.85–5.92) | 95 | 29 | 1.29 (0.74, 2.26) | 1.32 (0.74, 2.34) | 91 | 29 | 1.43 (0.79, 2.60) | 1.49 (0.81, 2.77) |
| Q4 ( | 95 | 30 | 0.95 (0.53, 1.70) | 0.91 (0.49, 1.66) | 84 | 25 | 1.07 (0.58, 1.97) | 1.07 (0.57, 2.03) |
| | 0.347 | 0.332 | 0.217 | 0.198 | ||||
| DEP | ||||||||
| Continuous | 1.00 (0.56, 1.77) | 0.94 (0.52, 1.68) | 0.98 (0.53, 1.78) | 0.91 (0.49, 1.68) | ||||
| Q1 ( | 90 | 33 | Reference | Reference | 84 | 32 | Reference | Reference |
| Q2 (5.86–10.12) | 92 | 33 | 1.01 (0.58, 1.78) | 1.10 (0.61, 1.97) | 85 | 30 | 1.09 (0.61, 1.95) | 1.21 (0.66, 2.22) |
| Q3 (10.12–16.15) | 91 | 32 | 0.98 (0.56, 1.72) | 1.00 (0.56, 1.77) | 79 | 29 | 1.01 (0.56, 1.82) | 1.04 (0.57, 1.91) |
| Q4 ( | 92 | 33 | 1.01 (0.58, 1.79) | 1.02 (0.57, 1.82) | 86 | 30 | 1.05 (0.58, 1.91) | 1.07 (0.58, 1.98) |
| | 0.996 | 0.778 | 0.815 | 0.590 | ||||
| DETP | ||||||||
| Continuous | 0.74 (0.41, 1.32) | 0.68 (0.37, 1.26) | 0.72 (0.39, 1.32) | 0.66 (0.35, 1.26) | ||||
| Q1 ( | 91 | 33 | Reference | Reference | 84 | 32 | Reference | Reference |
| Q2 (2.14–3.49) | 90 | 33 | 1.32 (0.73, 2.39) | 1.44 (0.77, 2.66) | 81 | 30 | 1.38 (0.75, 2.55) | 1.52 (0.80, 2.88) |
| Q3 (3.49–6.28) | 91 | 32 | 1.53 (0.85, 2.77) | 1.56 (0.84, 2.87) | 83 | 29 | 1.37 (0.73, 2.56) | 1.40 (0.73, 2.68) |
| Q4 ( | 93 | 33 | 2.07 (1.17, 3.68) | 2.17 (1.19, 3.93) | 86 | 30 | 2.11 (1.16, 3.85) | 2.30 (1.23, 4.30) |
| | 0.231 | 0.146 | 0.274 | 0.180 | ||||
| Total DAP | ||||||||
| Continuous | 1.00 (0.55, 1.79) | 0.91 (0.50, 1.66) | 0.96 (0.52, 1.78) | 0.85 (0.45, 1.61) | ||||
| Q1 ( | 94 | 29 | Reference | Reference | 90 | 28 | Reference | Reference |
| Q2 (113.42–200.42) | 83 | 40 | 0.82 (0.46, 1.45) | 0.88 (0.49, 1.59) | 71 | 39 | 0.79 (0.44, 1.42) | 0.90 (0.49, 1.66) |
| Q3 (200.42–332.46) | 96 | 28 | 1.31 (0.76, 2.25) | 1.64 (0.93, 2.91) | 89 | 21 | 1.40 (0.80, 2.45) | 1.89 (1.04, 3.43) |
| Q4 ( | 92 | 34 | 0.77 (0.43, 1.38) | 0.86 (0.48, 1.56) | 84 | 33 | 0.60 (0.32, 1.12) | 0.68 (0.36, 1.30) |
| | 0.957 | 0.628 | 0.988 | 0.526 | ||||
| PYR | ||||||||
| 3PBA | ||||||||
| Continuous | 0.78 (0.46, 1.32) | 0.81 (0.47, 1.39) | 0.81 (0.47, 1.40) | 0.84 (0.48, 1.46) | ||||
| Q1 ( | 92 | 34 | Reference | Reference | 86 | 28 | Reference | Reference |
| Q2 (0.44–0.73) | 92 | 32 | 1.29 (0.73, 2.30) | 1.22 (0.68, 2.21) | 80 | 30 | 1.22 (0.66, 2.23) | 1.17 (0.63, 2.19) |
| Q3 (0.73–1.38) | 86 | 37 | 1.27 (0.71, 2.27) | 1.26 (0.69, 2.29) | 76 | 37 | 1.40 (0.77, 2.56) | 1.39 (0.75, 2.60) |
| Q4 ( | 95 | 28 | 1.56 (0.88, 2.76) | 1.55 (0.86, 2.79) | 92 | 26 | 1.94 (1.08, 3.50) | 2.03 (1.10, 3.74) |
| | 0.306 | 0.403 | 0.287 | 0.349 | ||||
Note: 3PBA, 3-phenoxybenzoic acid; CI, confidence interval; DAP, dialkyl phosphate; DEP, diethylphosphate; DETP, diethylthiophosphate; DMP, dimethylphosphate; DMTP, dimethylthiophosphate; OP, organophosphate; OR, odds ratio; PYR, pyrethroid; Q1–4, quartiles 1–4.
.
Urine concentrations of pesticide metabolites were adjusted for creatinine then .
The cut point of OP and PYR metabolites was determined in a sample size of 496 in the analysis for infertility.
Adjusted for age, prepregnancy BMI, age at menarche, current smoking, education, annual household income, “Have you found that you could not cope with all the things that you had to do?”, and “How often have you been able to control irritations in your life?” in logistic regression models.